Cluster Headache

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2019-06-04
FDA Approved: EMGALITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for EMGALITY (galcanezumab) by Eli Lilly and Company. The approval covers a change to the product's …